Astrana Health, INC Form 4 insider transactions

Astrana Health's CEO, Brandon Sim, reported the acquisition of restricted stock units and holdings in common stock through direct and indirect ownership, including holdings in irrevocable trusts.

Director Thomas S. Lam reports acquisition of restricted stock grants and adjustments to beneficial ownership in Astrana Health, Inc.

Kenneth T. Sim, Executive Chairman of Astrana Health, reports acquisition and disposal of common stock, including restricted shares, through various trusts and entities.

Astrana Health's CEO, Brandon Sim, reported the surrender of shares to cover tax obligations and discloses holdings including restricted stock units and shares held in irrevocable trusts.

Director Linda Marsh exercised stock options and disposed of shares of Astrana Health, Inc. on September 10, 2024.

Director Thomas Lam exercised stock options and disposed of shares of Astrana Health, Inc. on September 9, 2024.

Director Mitchell W. Kitayama exercised stock options and disposed of shares of Astrana Health, Inc. on September 10, 2024.

Director John Chiang of Astrana Health, Inc. reports exercising stock options and disposing of shares on September 9, 2024.

Director David Schmidt reports exercising stock options and subsequent sale of shares in Astrana Health, Inc.

Director Linda Marsh reports acquisition of 3,564 shares of Astrana Health restricted stock, vesting on the earlier of August 13, 2025, or the 2025 annual meeting.

Director Mitchell W. Kitayama reports acquisition of 3,564 shares of Astrana Health restricted stock, vesting on the earlier of August 13, 2025, or the 2025 annual meeting.

Director Weili Dai reports acquisition of 3,564 shares of restricted Astrana Health stock, along with adjustments to existing holdings.

Director John Chiang reports transactions involving Astrana Health, Inc. common stock, including the acquisition of restricted shares and adjustments to beneficial ownership.

Director David Schmidt reports acquiring 3,564 shares of Astrana Health common stock and disposing of 9,314 shares in a recent transaction.

Director Matthew Mazdyasni reports changes in beneficial ownership of Astrana Health, Inc. common stock, including the acquisition of restricted shares and adjustments to holdings.

Dinesh M. Kumar, Chief Medical Officer of Astrana Health Enablement of Nevada, Inc., surrendered 794 shares of common stock to cover tax withholding obligations.

John Vong, Chief Accounting Officer of Astrana Health, Inc., reports a transaction involving the surrender of shares for tax withholding and acquisition of shares through the Employee Stock Purchase Plan.

Chief Accounting Officer John Vong surrendered 336 shares of Astrana Health stock to cover tax obligations related to vesting restricted stock.

Chandan Basho, COO and CFO of Astrana Health, surrendered 7,051 shares to cover tax obligations related to vesting restricted stock on May 16, 2024.

John Vong, Chief Accounting Officer of Astrana Health, Inc., disposed of 636 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock.

Chandan Basho, COO and CFO of Astrana Health, Inc., reported disposing of shares to cover tax withholding obligations related to vested restricted stock.

Astrana Health's CEO, Brandon Sim, surrendered shares to cover tax obligations related to vested restricted stock and provided updates on his holdings, including shares held in irrevocable trusts and the vesting schedule of restricted stock units.

Chandan Basho, CFO and COO of Astrana Health, Inc., reports the acquisition of 15,692 restricted stock units on April 2, 2024.

Astrana Health's CEO, Brandon Sim, filed a Form 4 detailing the grant of restricted stock units and adjustments to his beneficial ownership, including holdings in family trusts.